< Back to previous page
Researcher
Joost Schymkowitz
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Behavioural neuroscience
- Disciplines (KU Leuven):Proteins, Bioinformatics of disease, Structural bioinformatics and computational proteomics, Synthetic biology, Proteomics
Affiliations
- SCHYMKOWITZ AND ROUSSEAU LAB (Research group)
Responsible
From1 Jan 2017 → Today - Switch Laboratory (VIB-KU Leuven) (Division)
Member
From1 Jan 2011 → Today - Department of Cellular and Molecular Medicine (Department)
Member
From15 Sep 2010 → 31 Dec 2010
Infrastructure
1 - 1 of 1
- When size matters: a platform to study molecular interactions and multimerisation (Consortium coordinator)
Projects
1 - 10 of 64
See also Joost Schymkowitz for projects of Flanders Institute for Biotechnology.
Here below the projects of KU Leuven.
- Switch-ALight on: Shedding light on the molecular mechanisms of AL amyloidosisFrom1 Nov 2025 → TodayFunding: FWO junior postdoctoral fellowship
- Decoding and Predicting Pathogenic Determinants in Protein Misfolding and Amyloid InteractionsFrom28 Oct 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Assessing the interplay between ribosome pausing, co-translational folding, and proteostasis decline in ageingFrom1 Oct 2025 → TodayFunding: FWO junior postdoctoral fellowship
- Discovery and functional characterization of cyclic peptides in restoring alphab-crystallin pathogenic protein folding.From1 May 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Accurate assessment of biomolecular interactions during basic research and drug development.From1 Jan 2025 → TodayFunding: BOF - scientific equipment program
- Accurate assessment of biomolecular interactions during basic research and drug development.From1 Jan 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Deciphering TDP-43 molecular signatures in LATE: towards a multitarget diagnosisFrom1 Oct 2024 → TodayFunding: FWO junior postdoctoral fellowship
- Uncovering the implications of N-glycosylation and protein aggregation in human diseaseFrom1 Oct 2024 → 30 Sep 2025Funding: BOF - postdoctoral mandates
- Heterotypic Protein Interactions in Neurodegenerative DiseasesFrom23 Sep 2024 → TodayFunding: FWO fellowships
- The Hidden Biology of Inclusion BodiesFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 190
See also Joost Schymkowitz for publications of Flanders Institute for Biotechnology.
Here below the publications of KU Leuven.
- From computational design to synthetic antibodies: a rational approach to antibody discovery(2025)
- Energetic profiling reveals thermodynamic principles underlying amyloid fibril maturation.(2025)Published in: Nature CommunicationsISSN: 2041-1723Issue: 1Volume: 16Pages: 10081
- A versatile platform for combinatorial antibody library cloning and NGS-based quality control with high accuracy(2025)Published in: Nucleic Acids ResearchISSN: 0305-1048Issue: 19Volume: 53
- Toward a thermodynamic taxonomy of amyloid fibrils(2025)Published in: StructureISSN: 0969-2126Issue: 10Volume: 33Pages: 1628 - 1630
- AXZ viewer: a web application to visualize unprocessed AFM-IR data(2025)Published in: BioinformaticsISSN: 1367-4803Issue: 10Volume: 41
- [11C]HSP990 PET as a translational tool to investigate the role of Hsp90 in tumours and support the development of Hsp90 therapeutics(2025)Published in: EJNMMI Radiopharmacy and ChemistryISSN: 2365-421XIssue: 1Volume: 10
- Untangling Alzheimer's Disease: From nanoscale spectroscopy to cellular vulnerability(2025)
- Chemical Synthesis of Medin via a Removable Aggregation-Suppressing Linker(2025)Published in: JOURNAL OF PEPTIDE SCIENCEISSN: 1075-2617Issue: 8Volume: 31
- EXPLORING HSP90 AS A TARGET FOR CANCER PET IMAGING(2025)
- Mimicking the structure and function of tau folds associated with disease(2025)Published in: Nature ChemistryISSN: 1755-4330Issue: 6Volume: 17Pages: 793 - 794
Patents
1 - 10 of 10
- Means and methods for the treatment of pathological aggregation
- Means and methods for the prediction of amyloid core sequences
- Molecules targeting proteins
- Molecules targeting ras protein
- Molecules targeting mutant ras protein
- Carbon dioxide generation
- Beta-lactamase inhibitors
- Molecules targeting mutant ras protein
- Means and methods for the prediction of amyloid core sequences
- Means and methods for the treatment of pathological aggregation
Linked dataset
1 - 3 of 3
- Composition and liquid-to-solid maturation of protein aggregates contribute to bacterial dormancy development and recovery
- Composition and liquid-to-solid maturation of protein aggregates contribute to bacterial dormancy development and recovery
- Composition and liquid-to-solid maturation of protein aggregates contribute to bacterial dormancy development and recovery